Two key leaders of Mass General’s response to the COVID-19 epidemic answer questions about the virus’ infectiousness, how long the outbreak could last and much more.
Researchers and clinicians from Massachusetts General Hospital joined with colleagues from the Boston/Cambridge science ecosystem for a Grand Rounds session on March 12 to provide details on an unprecedented team effort to respond to the challenges posed by the COVID-19 pandemic.
The situation regarding the COVID-19 pandemic is changing on a moment-to-moment basis, and we want to make sure you stay informed. Here’s a handy list of resources that will keep you up to date on what’s happening at Mass General from both a clinical and research perspective. Coronavirus (COVID-19): Latest Updates on massgeneral.org This is […]
The second annual Mass General Research Institute Image Contest produced 46 amazing images from researchers across 15 centers and departments at Mass General. After two weeks of deliberation, the judges have finally selected a winner and eight finalists.
The Ragon Institute of MGH, MIT and Harvard have used flexible funding and a collaborative approach to identify a key weakness in the HIV virus.
While Candida auris may be getting all the headlines recently, the deadly fungus is one of many drug-resistant superbugs that infectious disease specialists have been fighting for years.
Young women and expecting mothers are one of the most-affected groups, and research has shown that HIV/AIDS can significantly increase the chances of both maternal deaths and still births. One Massachusetts General Hospital Discovery Foundation Fellow has witnessed the disease’s impact first-hand and is determined to help and give back to her community.